Patient-reported outcomes (PROs) can be included in clinical trials as primary or secondary
endpoints and are increasingly recognized by regulators, clinicians, and patients as …

Patient-reported outcomes (PROs) are used in clinical trials to provide valuable evidence on
the impact of disease and treatment on patients' symptoms, function and quality of life. High …

Importance Patient-reported outcome (PRO) data from clinical trials can provide valuable
evidence to inform shared decision making, labeling claims, clinical guidelines, and health …

Importance Patient-reported outcomes (PROs) can inform health care decisions, regulatory
decisions, and health care policy. They also can be used for audit/benchmarking and …

Introduction Cancer and corresponding available treatments are associated with substantial
symptoms and functional limitations. In this context, collection of patient-reported outcomes …

Purpose The quality of patient-reported outcome (PRO) data can be compromised by non-
response (NR) to scheduled questionnaires, particularly if reasons for NR are related to …

Aims To synthesise the available body of qualitative studies relating to clinical research
nurses' experiences of their role. Methods A systematic search of the literature in five …

Background PROMs can help healthcare professionals gain an improved understanding of
patients' physical burdens, functional levels, and (health-related) quality of life throughout …

PURPOSE: Adverse event (AE) reporting is essential in clinical trials. Clinician interpretation
can result in under-reporting; therefore, the value of patient self-reporting has been …

Background Patient-reported adverse events may be a useful adjunct for assessing a drug's
tolerability in dose-finding oncology trials (DFOT). We conducted surveys of international …